Cationic Polymers as Transfection Reagents for Nucleic Acid Delivery

Area of Science:

• Biomedical Engineering
• Gene Therapy
• Materials Science

Background:

• Nucleic acid therapy holds potential for treating diseases via gene augmentation, suppression, or editing.
• A major challenge is the inefficient cellular entry of naked nucleic acid molecules.
• Effective delivery systems are crucial for realizing the therapeutic potential of nucleic acids.

Purpose of the Study:

• To review the role of cationic polymers as non-viral vectors for nucleic acid delivery.
• To highlight the advantages of cationic polymers, including ease of synthesis and structural control.
• To discuss biodegradable cationic polymers and their future prospects in gene therapy.

Main Methods:

• Review of literature on cationic polymers for nucleic acid delivery.
• Description of how cationic polymers form nanoparticles with nucleic acids.
• Discussion of the mechanisms by which these nanoparticles facilitate cellular uptake and gene expression/inhibition.

Main Results:

• Cationic polymers effectively complex with nucleic acids, forming nanoparticles for enhanced cellular delivery.
• These nanoparticles facilitate the crossing of cellular barriers, enabling therapeutic gene expression or suppression.
• Biodegradable cationic polymers represent a particularly promising subclass of delivery vehicles.

Conclusions:

• Cationic polymers are versatile and effective non-viral delivery systems for nucleic acid therapy.
• Their ability to form nanoparticles and their tunable properties make them ideal for gene augmentation, suppression, and editing.
• Further development, particularly of biodegradable variants, is essential for advancing nucleic acid-based therapeutics.